TrialLipids in health and disease2015

Ezetimibe ameliorates atherogenic lipids profiles, insulin resistance and hepatocyte growth factor in obese patients with hypercholesterolemia.

Hisashi Adachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.